Ligand Pharmaceuticals
LGND
#3647
Rank
A$5.34 B
Marketcap
A$271.68
Share price
-1.67%
Change (1 day)
46.05%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): A$93.08 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.25 Billion. In 2024 the company made an earning of A$8.33 Million a decrease over its 2023 earnings that were of A$96.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$93.08 M1016.93%
2024 A$8.33 M-91.37%
2023 A$96.55 M-7.59%
2022 A$0.10 B4%
2021 A$0.10 B296.42%
2020 A$25.34 M-97.97%
2019 A$1.24 B275.62%
2018 A$0.33 B237.48%
2017 A$98.58 M49.05%
2016 A$66.13 M55.41%
2015 A$42.55 M36.87%
2014 A$31.09 M29.59%
2013 A$23.99 M1309.35%
2012 A$1.7 M-43.97%
2011 A$3.03 M-113.19%
2010 -A$23.04 Million59.86%
2009 -A$14.42 Million-61.33%
2008 -A$37.27 Million-58.75%
2007 -A$90.35 Million20.52%
2006 -A$74.96 Million81.27%
2005 -A$41.36 Million
2003 -A$28.8 Million-20.6%
2002 -A$36.26 Million4.38%
2001 -A$34.74 Million-48.83%
2000 -A$67.88 Million-19.74%
1999 -A$84.58 Million-19.06%
1998 -A$0.11 Billion126.71%
1997 -A$46.09 Million-5.83%
1996 -A$48.95 Million136.23%
1995 -A$20.72 Million-33.97%
1994 -A$31.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.37 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-A$92.91 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$13.99 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$34.66 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.79 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$33.78 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.05 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.41 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.63 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA